Left Ventricular Assist Device (LVAD) Market is forecast to reach USD 2.32 Billion by 2026| Sunshine Heart, CorWave, Apaxis Inc., Jarvik Heart, HeartWare International, etc.

The Global Left ventricular assist device (LVAD) Market is forecast to reach USD 2.32 Billion by 2026, according to a new report by Reports and Data.

Various factors drive the growth of the LVAD market. Change in lifestyle has been one of the essential elements that have resulted in boosting the growth of this sector. It is because of changing lifestyle, individuals are exposed to habits like smoking and alcohol consumption.

Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/1477

Companies considered and profiled in this market study

Sunshine Heart, CorWave, Apaxis Inc., Sun Medical Technology Research, Evaheart, Abiomed, HeartWare International, Jarvik Heart, HeartWare International, Reliantheart, Transonic, Thoratec, Terumo.

It is because of association with these habits, individuals have become more prone to cardiovascular disease that has resulted in increased demand for LVAD. With changing lifestyle, dietary habits of individuals are also changing, which is leading to an increased rate of obesity. Obesity is one of the underlying reason for cardiovascular diseases. Across the globe, more than 3 billion individuals are affected by obesity. With such a rise in the rate of obesity, there has been an increase in the demand for cardiovascular care, which in turn has resulted in promoting the LVAD market.

In addition to that, developments in the healthcare sector have resulted in a rise in the geriatric population. This section of the population is highly prone to cardiovascular diseases, which has resulted in an increased demand for cardiovascular care. Such a rise in demand for cardiovascular care has a positive impact on the market growth of the industry. Apart from that, cardiovascular diseases require continuous support, and, an increase of such conditions have increased the burden on care providing organizations. To cope up with such an increased burden and to ensure a quality life for care users, LVAD has become an indispensable part of cardiac care. Each year, 18 million deaths occur across the globe due to cardiovascular diseases. Such high death rate associated with cardiovascular diseases have promoted increased investment in the healthcare sector to minimize the number of deaths related to the condition which also has a positive impact on the growth rate of the market.

Further key findings from the report suggest

1 Changing lifestyle, rise in geriatric population, and increased investment in the healthcare sector are some of the factors that have resulted in boosting the growth of the market.

2 The Left ventricular assist device (LVAD) market held a market share of USD 1.06 Billion in the year 2018 and is forecasted to witness a CAGR of 11.3% during the forecast period.

3 In the end-user segment, hospitals yielded the highest revenue of USD 0.64 Billion in 2018 with a CAGR of 11.5% during the forecast period. The requirement of providing care services to various health conditions that require cardiac support have resulted in this segment to dominate the market.

4 Geriatric population is highly susceptible to cardiovascular diseases. In regards to Age group, 60-79 years segment can be seen to occupy the largest market share that generated USD 0.50 Billion in 2018 with a growth rate of 11.6% during the forecast period.

To read the full report now, with industry-wide coverage, visit: https://www.reportsanddata.com/checkout-form/1477

For the purpose of this report, according to Type, Age group, Pump type, Application, End-user, and Region:

Type Outlook (Revenue, USD Billion; 2016-2026)

Transcutaneous LVAD
Implantable LVAD

Age group Type Outlook (Revenue, USD Billion; 2016-2026)

20-39 years
40-59 years
60-79 years

Pump type Outlook (Revenue, USD Billion; 2016-2026)

Pulsatile volume-displacement pumps
First-Generation Devices
Axial flow pumps
Second-Generation Devices
Continuous flow centrifugal pumps
Third-Generation Devices

Application Type Outlook (Revenue, USD Billion; 2016-2026)

Bridge-to-Recovery (BTR) Therapy
Bridge-to-Transplant (BTT) Therapy
Destination Therapy
Bridge-to-Candidacy (BTC) Therapy

End-user Outlook (Revenue, USD Billion; 2016-2026)

Cardiology Centers
Hospitals

Regional Outlook (Revenue, USD Billion; 2016-2026)

North America
Europe
Asia Pacific
MEA
Latin America

Find the extensive Report Description, TOC and Table of Figure @ https://www.reportsanddata.com/report-detail/left-ventricular-assist-device-lvad-market

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.